Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | CASR | P41180 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573208 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL27889264 | 0.86 | ALDH1A1 (0.56) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL5583400 | 0.86 | ALDH1A1 (0.56) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL5583434 | 0.85 | ALDH1A1 (0.56) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL13347474 | 0.84 | ALDH1A1 (0.59) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL4361293 | 0.84 | ALDH1A1 (0.55) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL12920011 | 0.84 | ALDH1A1 (0.43) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL5583367 | 0.84 | ALDH1A1 (0.51) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL5583285 | 0.84 | ALDH1A1 (0.51) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA | |
| SCHEMBL23072537 | 0.82 | ALDH1A1 (0.52) | ALDH1A1CYP1A2TSHRSMN1; SMN2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7713634-B2 | Non-linear silicon compound, method of manufacturing oligomer probe array using the same, substrate for oligomer probe array with the same, and oligomer probe array with the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-11 | — | — | US | disclosed |
| US-7713634-B2 | Non-linear silicon compound, method of manufacturing oligomer probe array using the same, substrate for oligomer probe array with the same, and oligomer probe array with the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-11 | — | — | US | disclosed |
| US-20080107660-A1 | Binding Agents | SELF COLIN | 2008-05-08 | — | — | US | disclosed |
| US-20080057322-A1 | Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-03-06 | — | — | US | disclosed |
| US-20080057322-A1 | Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-03-06 | — | — | US | disclosed |
| EP-1723418-A2 | BINDING AGENTS | Bioenhancementsments Ltd. (GB) | 2006-11-22 | — | — | EP | disclosed |
| EP-0871673-B1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | BIOENHANCEMENTS LTD (GB) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005083431-A2 | BINDING AGENTS | BLOENHANCEMENTS LIMITED (GB) | 2005-09-09 | — | — | WO | disclosed |
| US-20040197336-A1 | Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety | SELF COLIN HENRY (GB) | 2004-10-07 | — | — | US | disclosed |
| EP-0871673-A1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | Bioenhancementsments Ltd. (GB) | 1998-10-21 | — | — | EP | disclosed |
| WO-1996034892-A1 | BISPECIFIC ANTIBODIES IN WHICH THE BINDING CAPABILITY IS REVERSIBLY INHIBITED BY A PHOTOCLEAVABLE MOIETY | BIOENHANCEMENTS LTD. (GB) | 1996-11-07 | — | — | WO | disclosed |
| US-5434272-A | Photo-labile compounds, their synthesis and use as fluorophores | MEDICAL RESEARCH COUNCIL (GB) | 1995-07-18 | — | — | US | disclosed |
| WO-1992008720-A1 | PHOTO-LABILE COMPOUNDS, THEIR SYNTHESIS AND USE AS FLUOROPHORES | MEDICAL RESEARCH COUNCIL (GB) | 1992-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080057322-A1 | Non-Linear Silicon Compound, Method of Manufacturing Oligomer Probe Array Using the Same, Substrate For Oligomer Probe Array With the Same, and Oligomer Probe Array With the Same | NONO, SPTBN1, SKIC8 | ALDH1A1 4399/4885CYP1A2 4678/4885TSHR 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.